Buy United Therapeutics Corporation Stocks - View UTHR Live Price (2025)

UTHR

TYPE Stocks

GROUP Stocks

BASE United Thera...

SECOND US Dollar

<% (signals.list.current.rate).substr(0,7) %>

<% (signals.list.current.absolute).substr(0,9) %> (<% signals.list.current.percentage|toFixed:2 %>%)

MARKETS TREND

OPEN

<% (signals.list.current.openrate).substr(0,9) %>

HIGH

<% (signals.list.current.high).substr(0,9) %>

LOW

<% (signals.list.current.low).substr(0,9) %>

START TRADING

Multi Charts

UTHR Signals

DON'T WANT TO MISS ANY SIGNAL? GO PREMIUM

ACCESS ALL FX, COMMODITIES & CRYPTO SIGNALS. GO PREMIUM

<% signal.pair %> (<% signal.rate %>) <% signal.action %>

<% signal.status %>

<% signal.analyst %>

Long Term

Entry Price

Stop Loss

Take Profit

PREMIUM ONLY

<% signal.stopLoss %> N/A

PREMIUM ONLY

<% signal.takeProfit %> N/A

PREMIUM ONLY

GO PREMIUM

TRADE NOW

GET READY

<% signal.analyst %>

<% signal.comment %>

Description

<% signal.description %>

LATEST ANALYSIS

<% item.time_ago %> Ago

<% item.title %>

<% item.deltaTime %>

Full Analysis Feed

Last Updated: Dec 24, 2025 01:29:57 PM (GMT)

UTHR: The current market price is 517.13, which shows a percentage change of 0.00% from the previous close.

Support and Resistance Levels The first support level is 516.93, the second support level is 516.65, and the third support level is 516.50. Resistance levels are 517.30, 517.50, and 517.70. The pivot point is at 517.10.

Indicators The RSI is at 45.19, indicating a neutral position. The ATR stands at 0.01429, suggesting low volatility. The ADX is at 92.41, indicating a strong trend. The 50-day SMA is 516.92 and the 200-day EMA is 516.20. The Parabolic SAR is 516.93.

Market Sentiment The market is bearish as the price is below the pivot point of 517.10 and indicators suggest selling.

UTHR Signals & Technical Analysis

Last Updated: <% indicators.interval.updated|date:'MMM d, y h:mm:ss a' %>

Market Trend

Strong Sell

Sell

Neutral

Buy

Strong Buy

Loading Market Trend ...

Market Sentiment

BUY: <% indicators.sentiment.buy.length %> SELL: <% indicators.sentiment.sell.length %> NEUTRAL: <% indicators.sentiment.neutral.length %>

Strong Sell

Sell

Neutral

Buy

Strong Buy

Trend Indicators

NAME

VALUE

ACTION

Bollinger Bands

UPPER: <% indicators.data[indicators.interval.active].bbands.value.upper %>

MIDDLE: <% indicators.data[indicators.interval.active].bbands.value.middle %>

LOWER: <% indicators.data[indicators.interval.active].bbands.value.lower %>

Sell

Buy

Parabolic SAR

<% indicators.data[indicators.interval.active].sar.value %>

Sell

Buy

Standard Deviation

<% indicators.data[indicators.interval.active].stddev.value %>

High Volatility

Low Volatility

Oscillators

NAME

VALUE

ACTION

RSI(14)

<% indicators.data[indicators.interval.active].rsi.value %>

Sell

Buy

MACD(12,26)

<% indicators.data[indicators.interval.active].macd.value %>

Buy

Sell

Neutral

ATR

<% indicators.data[indicators.interval.active].atr.value %>

High Volatility

Low Volatility

STOCH(9,6)

<% indicators.data[indicators.interval.active].stochastics.value %>

Buy

Sell

ADX

<% indicators.data[indicators.interval.active].adx.value %>

High Volatility

Low Volatility

Moving Averages

PERIOD

SIMPLE

EXPONENTIAL

MA5

<% indicators.data[indicators.interval.active].sma5.value %> Buy Sell

<% indicators.data[indicators.interval.active].ema5.value %> Buy Sell

MA10

<% indicators.data[indicators.interval.active].sma10.value %> Buy Sell

<% indicators.data[indicators.interval.active].ema10.value %> Buy Sell

MA20

<% indicators.data[indicators.interval.active].sma20.value %> Buy Sell

<% indicators.data[indicators.interval.active].ema20.value %> Buy Sell

MA50

<% indicators.data[indicators.interval.active].sma50.value %> Buy Sell

<% indicators.data[indicators.interval.active].ema50.value %> Buy Sell

MA100

<% indicators.data[indicators.interval.active].sma100.value %> Buy Sell

<% indicators.data[indicators.interval.active].ema100.value %> Buy Sell

Pivot

PIVOT

CLASSIC

FIBONACCI

CAMARILLA

WOODIE

<% indicators.data[indicators.interval.active].pp.data.result.classic.s3 %>

<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.s3 %>

<% indicators.data[indicators.interval.active].pp.data.result.camarilla.s3 %>

<% indicators.data[indicators.interval.active].pp.data.result.woodie.s3 %>

<% indicators.data[indicators.interval.active].pp.data.result.classic.s2 %>

<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.s2 %>

<% indicators.data[indicators.interval.active].pp.data.result.camarilla.s2 %>

<% indicators.data[indicators.interval.active].pp.data.result.woodie.s2 %>

<% indicators.data[indicators.interval.active].pp.data.result.classic.s1 %>

<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.s1 %>

<% indicators.data[indicators.interval.active].pp.data.result.camarilla.s1 %>

<% indicators.data[indicators.interval.active].pp.data.result.woodie.s1 %>

<% indicators.data[indicators.interval.active].pp.data.result.classic.pp %>

<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.pp %>

<% indicators.data[indicators.interval.active].pp.data.result.camarilla.pp %>

<% indicators.data[indicators.interval.active].pp.data.result.woodie.pp %>

<% indicators.data[indicators.interval.active].pp.data.result.classic.r1 %>

<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.r1 %>

<% indicators.data[indicators.interval.active].pp.data.result.camarilla.r1 %>

<% indicators.data[indicators.interval.active].pp.data.result.woodie.r1 %>

<% indicators.data[indicators.interval.active].pp.data.result.classic.r2 %>

<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.r2 %>

<% indicators.data[indicators.interval.active].pp.data.result.camarilla.r2 %>

<% indicators.data[indicators.interval.active].pp.data.result.woodie.r2 %>

<% indicators.data[indicators.interval.active].pp.data.result.classic.r3 %>

<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.r3 %>

<% indicators.data[indicators.interval.active].pp.data.result.camarilla.r3 %>

<% indicators.data[indicators.interval.active].pp.data.result.woodie.r3 %>

About (UTHR) United Therapeutics Corporation

Company Background

United Therapeutics Corporation, traded under the symbol UTHR on the NASDAQ exchange, is a leading biotechnology company based in the United States. Founded in 1996 by Dr. Martine Rothblatt, United Therapeutics is committed to the development and commercialization of innovative products to address the unmet medical needs of patients with chronic and life-threatening conditions. The company focuses primarily on the treatment of pulmonary arterial hypertension (PAH) and has pioneered several therapies that significantly improve patients' quality of life.

Market Position

United Therapeutics holds a robust position in the biotechnology sector, particularly in the field of pulmonary medicine. The company's diverse portfolio includes several FDA-approved products such as Remodulin, Tyvaso, and Orenitram, which are designed to treat PAH. With a strong commitment to research and development, United Therapeutics actively invests in new therapies and technologies, including an innovative organ transplantation program that aims to revolutionize the field with xenotransplantation solutions. This proactive approach not only strengthens their product pipeline but also enhances their competitive edge in a rapidly evolving market.

Key Financial Highlights

As of the latest fiscal reports, United Therapeutics has demonstrated impressive financial performance, with significant revenue growth driven by increased sales of its specialty pharmaceuticals. The company's disciplined cost management and strategic investments in R&D have resulted in consistent profitability, enabling it to reinvest in innovative projects. With a robust cash position, United Therapeutics is well-equipped to navigate the competitive landscape and pursue future expansion opportunities. Additionally, the growing prevalence of PAH and the increasing demand for effective treatments position United Therapeutics for sustained growth and market leadership in the biopharmaceutical industry.

Conclusion

In summary, United Therapeutics Corporation (NASDAQ: UTHR) stands out as a key player in the biotechnology sector, dedicated to improving patient outcomes through innovative therapies. With a strong financial foundation and a commitment to groundbreaking research, United Therapeutics is poised for continued success as it addresses critical healthcare challenges and advances the field of pulmonary medicine.

Check all UTHR conversion rates

Related Stocks

JAZZ

Jazz Pharmaceuticals plc

Industry Biotechnology

Exchange NASDAQ

RVMD

Revolution Medicines Inc.

Industry Biotechnology

Exchange NASDAQ

FRES

Fresh2 Group Limited

Industry Biotechnology

Exchange NASDAQ